Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Status
- TERMINATED
- Phase
- PHASE3
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
ROTAHALER Device Optimization Study
- Status
- COMPLETED
- Phase
- PHASE1
Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
- Status
- COMPLETED
- Phase
- N/A
Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol
- Status
- WITHDRAWN
- Phase
- PHASE3
Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation
- Status
- COMPLETED
- Phase
- N/A
Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])
- Status
- COMPLETED
- Phase
- NA
Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
- Status
- TERMINATED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
- Status
- COMPLETED
- Phase
- N/A